Recent Headlines
Marlena Holter Named ALPCO’s Winter 2020 Diabetes Research Travel Grant Recipient
ALPCO's Winter 2020 Diabetes Research Travel Grant has been awarded to Marlena Holter, a DVM/PhD candidate from Cornell University’s College of Veterinary Medicine. Ms. Holter’s novel research focuses on GLP-1 regulated glucose regulation following vertical sleeve gastrectomy surgery to define the mechanisms underlying type 2 diabetes remission and metabolic improvement following bariatric surgery. - April 14, 2020 - ALPCO
HealthWare Systems Earns Better Business Bureau Accreditation
HealthWare Systems has earned its Better Business Bureau Accreditation. The revenue cycle management company is now a BBB Accredited Business. - March 20, 2020 - HealthWare Systems
Rare Diseases Research Funded by $220,000 in Grants from CABRI
In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principle investigator and undergraduate awardees for the 2020 academic year. “We are excited to support these scientists actively researching... - March 12, 2020 - Cayman Chemical Company
Epitope Diagnostics Has Proudly Introduced Immunoassay Kits Exclusively for the Qualitative Detection of COVID-19
The EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit and EDI™ Novel Coronavirus COVID-19 IgM ELISA Kits. With proven results from clinical testing in China, Epitope Diagnostics, Inc. is eager to cooperate and collaborate to combat the current COVID-19 situation. - March 06, 2020 - Epitope Diagnostics, Inc.
Clinical Guidelines for Physical Therapy in Huntington Disease
HSG Announces Publication of Clinical Guidelines for Physical Therapy in Huntington Disease - February 27, 2020 - Huntington Study Group
The Cardiac & Vascular Institute First in Florida to Enroll Patients in New Clinical Trial Studying LimFlow Therapy
The Cardiac & Vascular Institute (TCAVI) announced it is the first in Florida to perform a successful procedure in the PROMISE II pivotal study of the LimFlow Percutaneous Deep Vein Arterialization System for the treatment of “no option” Chronic Limb-Threatening Ischemia, a severe... - February 20, 2020 - The Cardiac & Vascular Institute
ASAlaser: Internationalisation and Sustainability Are the 2019 Cornerstones
The evaluation of new markets in which to expand and the retention of existing ones are the mainstay of the year which has just closed for the company, which has recorded a considerable growth in the Far East, Europe, Central and South America. The "Customer Satisfaction 2019" results are certainly noteworthy. Training remains the cornerstone of the activity, with more than 200 training sessions for Human and Vet distributors from over 90 countries and 1400 hours for company staff. - February 06, 2020 - ASA srl
The Pediatric Cancer Research Foundation Funds 6 New Research Grants in 2020
The Pediatric Cancer Research Foundation (PCRF) is proud to award 6 new grants with a total of 18 grants in 2020. These new grants are comprised of three Basic Science, one Translational and three Emerging Research grants totaling $675,000. With these new additions, PCRF will fund over $2.2 million... - January 25, 2020 - Pediatric Cancer Research Foundation
ALS Therapy Development Institute Announces Naming of Augie’s Quest Translational Research Center
“It’s really incredible. For 15 years, Augie’s Quest has been dedicated to raising the critical funds and broad awareness needed to help fast-track ALS TDI’s cutting-edge ALS research – specifically providing ALS TDI with more than $150 million to advance its efforts to end ALS,” commented Steven Perrin Ph.D., CEO of ALS TDI. - January 24, 2020 - ALS Therapy Development Institute
North County Health Services Host's 2020 Passion for Healing Gala
North County Health Services (NCHS) will host its 3rd annual gala on April 4, 2020. The Passion for Healing “Roaring into the 20s” Gala will take place at the beautiful Westin Carlsbad Resort & Spa. The event will feature a Roaring Twenties theme. Guests will be transported to... - January 13, 2020 - NCHS
New NF-kB Panel of Antibodies from AbboMax and Human Diseases
NF-kB is a protein complex that controls the transcription of DNA. It is a heterodimer sequestered in the cytoplasm. In response to activation NF-kB translocates to the nucleus to 'turn on' the expression of specific genes that keeps a cell proliferating and protects it from apoptosis. AbboMax has developed a panel of NF-kB related antibodies. - December 22, 2019 - AbboMax, Inc.
Three American Association for Anatomy Members Named AAAS Fellows
Three distinguished members of the American Association for Anatomy (AAA) have been elected by their American Association for the Advancement of Science (AAAS) peers to the 2019 Class of AAAS Fellows in three different sections. They are Drs. Rick Sumner (Medical Sciences), Lynne Opperman (Dentistry and Oral Health Sciences), and David Ornitz (Biological Sciences). - December 20, 2019 - American Association for Anatomy
ALS TDI Collaboration with Google’s Project Euphonia Highlighted in Documentary Series Featuring Former NFL Player Tim Shaw “The Age of A.I.” Hosted by Robert Downey Jr.
The ALS Therapy Development Institute (ALS TDI), the world’s foremost drug discovery lab focused solely on finding treatments and cures for ALS, today proudly announced that it is featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes... - December 18, 2019 - ALS Therapy Development Institute
HealthWare Systems Launches Updated Website
HealthWare Systems Launches Updated Website: Announcing updates to the revenue cycle management technology website, www.healthwaresystems.com. - December 13, 2019 - HealthWare Systems
ALS Therapy Development Institute Reflects on the Impact of Pete Frates and the Ice Bucket Challenge
On Monday it was announced that Pete Frates passed away due to complications from ALS. Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness. Though it has been five years since the Challenge,... - December 11, 2019 - ALS Therapy Development Institute
Neurology Associates Neuroscience Center Recruiting Additional Neurologists
Neurology Associates Neuroscience Center is hiring more board-certified neurologists to accommodate its increasing patient load. To date, Neurology Associates employs six neurologists, several of whom specialize in areas including movement disorders, multiple sclerosis, epilepsy, and other... - December 08, 2019 - Neurology Associates
The ASAcampus Team Takes Part in XENOGRISS, One of the Italian Experiments by the Italian Space Agency, for the ESA Beyond Mission
The Space-X 19 was launched at 12:29 EST on December 5 last; on-board it carries some scientific experiments that will be undertaken on the International Space Station during the Beyond Mission, led by the Italian astronaut Luca Parmitano from the European Space Agency. - December 08, 2019 - ASA srl
ALPCO Announces Deadline for Winter 2020 Diabetes Research Travel Grant Award
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
Red Pill CBD CEO Says He Was Pleased to Get a Warning Letter from the FDA
On November 25, 2019, the FDA posted on their site 15 companies that received warning letters for illegally selling products containing cannabidiol (CBD), Red Pill Medical, Inc. was one of them. “I know it may sound crazy, but I was pleased with the FDA warning letter,” said Gregory A. - November 28, 2019 - Red Pill Medical, Inc.
New York Imaging Specialists Announces Grand Opening in Port Jefferson Station
New York Imaging Specialists announces the grand opening of its newest facility, at 1500 Route 112, Building 2A in Port Jefferson Station, NY 11776. New York Imaging Specialists features board-certified radiologists and the most modern imaging equipment. The ACR-accredited facility utilizes... - November 28, 2019 - New York Imaging Specialists
Dr. Varghese Cherian Joins New York Imaging Specialists
New York Imaging Specialists welcomes Varghese Cherian, MD, to its group of board-certified radiologists. Dr. Cherian will be practicing at New York Imaging Specialists’ newest facilities at 1500 Route 112, Building 2A in Port Jefferson Station and 640 County Road 39 in Southampton. Dr. - November 28, 2019 - New York Imaging Specialists
ASA: Honourable Mention at the C2A Award
The company from Veneto receives an award at the Creative Communication Award programme in Los Angeles for its campaigns dedicated to the HIRO TT and MiS devices. The award conferred for “Brand identity” is the result of the collaboration with Studio D’Orsi. - November 27, 2019 - ASA srl
Good News: a Panel of TGF-Beta and TGF-Beta Receptor Antibodies is Created by Abbomax
TGF-β regulates multiple biological processes, including embryonic development, adult stem cell differentiation, proliferation, homeostasis, immune regulation, wound healing, and inflammation. Multiple cells synthesize TGF-β and many cells have specific receptors for this peptide. AbboMax created a panel of TGF-β and TGF-β receptors antibodies. AbboMax, Inc. has been developing & manufacturing antibodies, FFPE cell pellets slides, for many years in California. - November 23, 2019 - AbboMax, Inc.
AT-1501, a Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trials
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. - November 20, 2019 - ALS Therapy Development Institute
Phase III Clinical Study of Valbenazine for Chorea in Huntington Disease
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
ALPCO Launches Analytically Specific Human and Rodent STELLUX® Glucagon ELISA
ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. - November 06, 2019 - ALPCO
Compliance Resources from Nationwide Testing Association, Inc.
Nationwide Testing Association, Inc. recently launched a new resource center online. The resource center is aimed at keeping clients up-to-date on all things compliance. In Nationwide Testing Association, Inc.'s resource center, you will find training videos, and news releases on current industry topics. - November 05, 2019 - Nationwide Testing Association Inc.
ALPCO’s New Fecal Calprotectin ELISA with Superior Clinical Accuracy Receives FDA 510(k) Clearance
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test. The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS. - October 30, 2019 - ALPCO
Cayman Awarded 1.5 Million Dollar SBIR Grant
The NIH’s National Institute of Arthritis and Musculoskeletal & Skin Diseases (NIAMS) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop its patented small molecule bone repair agent KMN-159. - September 25, 2019 - Cayman Chemical Company
Scintica Instrumentation and Aspect Imaging Announce Exclusive Agreement for Pre-Clinical MRI Imaging Products
Scintica Instrumentation Inc. is excited to announce its exclusive distribution agreement with Aspect Imaging for the M-Series(TM) MRI systems for scientific research. With more than 100 MRI installations worldwide, Aspect’s compact MRI systems are self-shielding, cryogen free and do not need... - September 18, 2019 - Scintica Instrumentation
Neurology Associates Updates Name to Embrace Its Neuroscience Roots, Comprehensive Expertise
All Processes, Data Stay the Same for Patients, Providers - September 14, 2019 - Neurology Associates
Cambridge Cider Social Invites You to Celebrate Autumn by Tasting Hard Ciders and Donuts at a Fun Outdoor Festival
On October 24, 2019 join the ALS Therapy Development Institute in Cambridge for an outdoor celebration of autumn with hard cider, apple cider donuts, seasonal snacks, music, and fun – all in support of a great cause. - September 10, 2019 - ALS Therapy Development Institute
Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology for Cytoplasmic Disulphide Formation, (for Active Folding) for Complex Therapeutic Protein
Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®, is established for the high-level expression of homogeneously folded disulfide bond containing proteins in the cytoplasm of E. Coli. The technology offers all cost benefits of... - September 10, 2019 - Paras Biopharmaceuticals Finland Oy
Biosynthetic Technologies Inks Patent License Agreement with Cayman Chemical for the Global Pharmaceutical and R&D Markets
Biosynthetic Technologies (BT) today announced it has signed on with Cayman Chemical for the production and distribution of novel Estolide compounds for pharmaceutical testing applications. BT is excited to partner with Cayman Chemical to provide discovery and pre-clinical development services to... - September 05, 2019 - Cayman Chemical Company
The Pediatric Cancer Research Foundation to Host 3rd Annual Dine & Donate During Childhood Cancer Awareness Month
The Pediatric Cancer Research Foundation to host its annual fundraiser to benefit pediatric cancer research. - August 28, 2019 - Pediatric Cancer Research Foundation
Neurology Associates Earns MRI Certification from Intersocietal Accreditation Commission
The designation not only guarantees that Neurology Associates adheres to and complies with stringent MRI standards and practices, it also extends coverage to patients insured by Medicare. - August 25, 2019 - Neurology Associates
Zifo RnD Solutions and Scilligence Announce Strategic Partnership
Zifo RnD Solutions and Scilligence Corporation announce a strategic partnership that enables Zifo to provide System Integrations Solutions for Scilligence suite of integrated informatics solutions. The partnership will help clients to easily select, evaluate, and implement solutions that fit their... - August 18, 2019 - Zifo
New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
8-year Study Tracks Central Lab Performance and Identifies Covance as Leading the Way in Clinical Investigator Satisfaction. - August 13, 2019 - Life Science Strategy Group, LLC
Dribble for the Cure Returns to St. John's University on Saturday, September 21, 2019
Dribble for the Cure at St. John's University to be held on Saturday, September 21, 2019. - August 08, 2019 - Pediatric Cancer Research Foundation
Advances in Medicine Cause New, Groundbreaking Drug by Quantum Genomics (QNNTF) to Help with Chronic Hypertension
Quantum Genomics are the creators of Firibastat, a first-in-class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system. It is estimated that there are around 150 million people... - August 05, 2019 - Quantum Genomics
American Association of Anatomists Gets Refresh as American Association for Anatomy
The American Association of Anatomists, the professional home for educators, researchers, and allied health professionals working in the anatomical sciences, has a new name and fresh look. The newly-named American Association for Anatomy is a diverse, inclusive, integrated, and international community. The new identity showcases the holistic nature of the organization, a vibrant new brand, and messaging focused on connecting science, knowledge, careers, research, and those working in anatomy. - August 05, 2019 - American Association for Anatomy
Brewing a Cure 4 ALS Fundraiser Invites You to Enjoy Regional Beers and Wines While Fundraising for ALS Research
On Saturday, August 10, 2019, the first-ever Brewing a Cure 4 ALS fundraiser will be held at Technology Square in Cambridge, MA. Brewing a Cure 4 ALS invites community members to enjoy craft beer, wine, music, and food with the goal of raising money for ALS research at the ALS Therapy Development... - July 31, 2019 - ALS Therapy Development Institute
On August 18, Wear Your Nerdiest Costume and Run for a Great Cause at the Race 4 Research 5K in Cambridge
On Sunday, August 18, the ALS Therapy Development Institute (ALS TDI) will host the annual Race 4 Research 5K and Walk in Technology Square, Cambridge. The event will feature a chip-timed nerdy 5K road race (costumes encouraged), a 4-mile ALS awareness walk and wheelchair ride along the Charles,... - July 26, 2019 - ALS Therapy Development Institute
Multiplex ELISAs Offer Powerful Profiling Capabilities
Cayman now offers multiplex immunoassay technology powered by Quansys Biosciences. This line of fully quantitative Q-Plex™ multiplex ELISAs and chemiluminescent Q-View™ imagers provides a highly sensitive means to simultaneously measure multiple markers using a single sample. - June 22, 2019 - Cayman Chemical Company
ASA: New Headquarters for the Company
Technology, sustainability, lean management are only a few of the guidelines followed when building the new company headquarters in Arcugnano. In the name of welfare and of the spirit of belonging, the new structure, which houses production and offices, has provided for the adoption of innovative solutions in space management and in the choice of furnishings. - June 21, 2019 - ASA srl
BraveHeart Wireless Announces FDA Clearance of the BraveHeart™ Life Sensor Cardiac Monitoring System
The BraveHeart™ Life Sensor Cardiac Monitoring system has been cleared for use in health care settings. The Life Sensor monitoring system securely captures patients’ heart rate and EKG data, and transmits the data to health care providers in real time. More than 28 million Americans diagnosed with heart disease may benefit - with this number growing each year. - June 20, 2019 - BraveHeart Wireless Inc.
Orangetheory Fitness and Augie’s Quest Collaboration Funds Innovative Research at the ALS Therapy Development
This past May over 1,100 members of Orangetheory Fitness ran, rowed, and lifted, earning “splat points,” which they turned into $4.5 million in donations for Augie’s Quest to Cure ALS. With this donation Augie’s Quest is supporting non-profit biotech, the ALS Therapy Development Institute (ALS TDI), to fast track cure-driven drugs for ALS. - June 20, 2019 - ALS Therapy Development Institute
New Research Benchmarks Pharma’s Changing Utilization of Real-World Evidence (RWE) and Its Impact on Contract Research Organizations (CROs)
Study Tracks Utilization of Real-World Data (RWD), Real-World Evidence (RWE) and Supportive Services and Implications to CROs. - June 11, 2019 - Life Science Strategy Group, LLC
Trek Across Country Raises Awareness of Childhood Cancer
Thomas Curran Walks to Raise $20,000 for Pediatric Cancer Research Foundation - June 09, 2019 - Pediatric Cancer Research Foundation
Health Choice PPO Selects Synergy Laboratories to Deliver High Quality, Cost-Effective Results
Health Choice PPO and Synergy Laboratories, two of Alabama’s leading healthcare companies have come together to provide the highest quality laboratory results to the physicians, hospitals and other medical professionals serving members of the Health Choice PPO network. - June 05, 2019 - Synergy Laboratories